Literature DB >> 11985967

beta-1,3-Glucan reduces growth of Mycobacterium tuberculosis in macrophage cultures.

Geir Hetland1, Per Sandven.   

Abstract

The effect of beta-1,3-D-glucans SSG, from Sclerotinia sclerotiorum, or soluble (sMG) or particulate (pMG) MacroGard from baker's yeast on growth of Mycobacterium tuberculosis H37Rv in cultures of peritoneal macrophages from BALB/c mice was examined. After 24 h intracellular bacteria from lysed macrophages were cultured and the number of cfu counted. SSG given with challenge, but not 24 h after, reduced the number of M. tuberculosis cfu significantly. pMG, but not sMG, given with challenge had an even stronger inhibitory effect, which was enhanced after serum opsonization of the particles. The effect of serum-treated pMG was abrogated by addition of a monoclonal antibody to CD11b. The results indicate that beta-glucans inhibit growth of M. tuberculosis in host cells in vitro, probably due to cellular stimulation and/or competitive inhibition of uptake of bacteria via CR3 (CD11b/18).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11985967     DOI: 10.1111/j.1574-695X.2002.tb00570.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  9 in total

1.  β-Glucans inhibit intracellular growth of Mycobacterium bovis BCG but not virulent Mycobacterium tuberculosis in human macrophages.

Authors:  Bret E Betz; Abul K Azad; Jessica D Morris; Murugesan V S Rajaram; Larry S Schlesinger
Journal:  Microb Pathog       Date:  2011-07-05       Impact factor: 3.738

2.  The effects of β-glucan isolated from Pleurotus ostreatus on methotrexate treatment in rats with adjuvant arthritis.

Authors:  Jozef Rovenský; M Stančíkova; K Svík; K Bauerová; J Jurčovičová
Journal:  Rheumatol Int       Date:  2009-12-23       Impact factor: 2.631

3.  Oral administration of beta-1,3/1,6-glucan to dogs temporally changes total and antigen-specific IgA and IgM.

Authors:  E Stuyven; F Verdonck; I Van Hoek; S Daminet; L Duchateau; J P Remon; B M Goddeeris; E Cox
Journal:  Clin Vaccine Immunol       Date:  2009-12-23

4.  Hybrid Curdlan Poly(γ -Glutamic Acid) Nanoassembly for Immune Modulation in Macrophage.

Authors:  Jeongyun Heo; Thomas A Sobiech; Hilliard L Kutscher; Lee Chaves; Dinesh K Sukumaran; Shanta Karki; Admire Dube; Paras N Prasad; Jessica L Reynolds
Journal:  Macromol Biosci       Date:  2020-12-07       Impact factor: 4.979

5.  β-Glucan Induces Protective Trained Immunity against Mycobacterium tuberculosis Infection: A Key Role for IL-1.

Authors:  Simone J C F M Moorlag; Nargis Khan; Boris Novakovic; Eva Kaufmann; Trees Jansen; Reinout van Crevel; Maziar Divangahi; Mihai G Netea
Journal:  Cell Rep       Date:  2020-05-19       Impact factor: 9.423

6.  Curdlan-Chitosan Electrospun Fibers as Potential Scaffolds for Bone Regeneration.

Authors:  Clément Toullec; Jean Le Bideau; Valerie Geoffroy; Boris Halgand; Nela Buchtova; Rodolfo Molina-Peña; Emmanuel Garcion; Sylvie Avril; Laurence Sindji; Admire Dube; Frank Boury; Christine Jérôme
Journal:  Polymers (Basel)       Date:  2021-02-10       Impact factor: 4.329

7.  Trained immunity contributes to the prevention of Mycobacterium tuberculosis infection, a novel role of autophagy.

Authors:  Jie Zhou; Jingzhu Lv; Chelsea Carlson; Hui Liu; Hongtao Wang; Tao Xu; Fengjiao Wu; Chuanwang Song; Xiaojing Wang; Ting Wang; Zhongqing Qian
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

8.  Fermented rye with Agaricus subrufescens and mannan-rich hydrolysate based feed additive to modulate post-weaning piglet immune response.

Authors:  Nienke de Groot; Fernando Fariñas; Lluís Fabà; Ellen Hambrecht; Carolina G Cabrera-Gómez; Francisco J Pallares; Guillermo Ramis
Journal:  Porcine Health Manag       Date:  2021-12-09

9.  The anti-tumorigenic mushroom Agaricus blazei Murill enhances IL-1β production and activates the NLRP3 inflammasome in human macrophages.

Authors:  Tsung-Teng Huang; David M Ojcius; John D Young; Yi-Hui Wu; Yun-Fei Ko; Tsui-Yin Wong; Cheng-Yeu Wu; Chia-Chen Lu; Hsin-Chih Lai
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.